Dr. Stephen Liu, member of the GRACE faculty, discusses immunotherapy for small cell lung cancer.

For more information visit www.cancerGRACE.org

Dr. Josh Bauml, member of the GRACE faculty, discusses emerging molecular targets in non small cell lung cancer for RET fusions.

For more information visit www.cancerGRACE.org

Dr. Josh Bauml, member of the GRACE faculty, discusses emerging molecular targets in non small cell lung cancer with a MET mutation.

for more information visit www.cancerGRACE.org

Dr. Jared Weiss, GRACE VP on the Board of Directors and Faculty for GRACE discusses updates for the treatment of Small Cell Lung Cancer.

For more info, visit www.cancerGRACE.org

Dr. Jared Weiss, Vice President of the GRACE Board of Directors and GRACE faculty, discusses the new TKIs for Stage IV Non Small Cell Lung Cancer mutations including MET, RET, and HER2.

Dr. Jared Weiss, Vice President of the GRACE Board of Directors and GRACE faculty, discusses the ADAURA trial; the first global trial for an EGFR inhibitor to show statistically significant and clinically meaningful benefit in adjuvant treatment of lung cancer.

For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.
Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.
Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.

In this series, the doctors discuss a series of cases related to EGFR Mutations. In this case, the discussion surrounds patient progression in a case with EGFR mutation, and what are the next steps.

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.
Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.
Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.

In this series, the doctors discuss a series of cases related to EGFR Mutations. In this case, the discussion surrounds a case with an EGFR Mutation and High PDL1. The discussion centers around the role of immunotherapy in treatment decisions.


For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.
Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center.
Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.

In this series, the doctors discuss a series of cases related to EGFR Mutations. In this case, the discussion surrounds an EGFR mutation with MET amplification. They review treatment decisions and the importance of the level of MET amplification.

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In part three of this three part video series update, presented in July of 2020, GRACE Faculty and Members of the Board of Directors continue their candid discussions regarding cancer and Covid-19.
GRACE Board Members Drs. H. Jack West, Jared Weiss and Ben Levy discuss cancer and Covid-19 and how the ongoing pandemic is effecting in person patient care.

Part 1 - How Has the Coronavirus Pandemic Changed Cancer Management in Patient Care
Part 2 - Update on the Use of Telemedicine in Patient Care During the Pandemic
Part 3 - Challenges and the Future Outlook for In Person Patient Care

To join the conversation, visit https://cancergrace.org/forum.